Jianning Wang

Dr. Jianning Wang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
ZXZhipeng Xu
Zhipeng Xu
WHWenxin Hu
Wenxin Hu
BWBin Wang
Bin Wang
TXTing Xu
Ting Xu
JWJianning Wang
Jianning Wang
DWDan Wei
Dan Wei
Xu Z, et al. Yonsei Med J. 2022 Jul;63(7):619-631. https://doi.org/10.3349/ymj.2022.63.7.619

28 September 2019 in FEBS Letters
Verified
Journal Article
Open access
PDF file
JFJiaxing Fan
Jiaxing Fan
WDWenzhi Du
Wenzhi Du
HZHui Zhang
Hui Zhang
YWYunchao Wang
Yunchao Wang
KLKai Li
Kai Li
JWJianning Wang
Jianning Wang
Prostate cancer (PCa) is one of the most common cancers in males and particularly tends to metastasize to bone. Currently, metastatic bone disease is incurable, and new therapies need to be developed. Our study aims to determine the role of miR‐127‐3p in PCa metastasis to bone. The results demonstrate that miR‐127‐3p is markedly reduced in bone metastasis‐positive PCa tissues relative to that in bone metastasis‐negative PCa tissues. Furthermore, overexpressing miR‐127‐3p inhibits PCa cell invasion and migration in vitro by targeting the proteasome β‐subunit PSMB5. Moreover, CCCTC‐binding factor (CTCF) transcriptionally inhibits miR‐127‐3p by interacting with the miR‐127‐3p promoter. Collectively, this study uncovers a novel mechanism of the CTCF/miR‐127‐3p/PSMB5 axis in promoting PCa bone metastasis, indicating that miR‐127‐3p could function as a promising therapeutic target against bone metastasis.

22 March 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
ZXZhipeng Xu
Zhipeng Xu
MLMin Liu
Min Liu
JWJin Wang
Jin Wang
KLKai Liu
Kai Liu
LXLiuyu Xu
Liuyu Xu
JWJianning Wang
Jianning Wang
Clear cell renal cell carcinoma (ccRCC) is a serious threat to human health worldwide, while its heterogeneity limits therapeutic success and leads to poor survival outcomes. Single-cell RNA-sequencing (scRNA-seq) is an important technology, which provides deep insights into the genetic characteristics of carcinoma. In this study, we profiled the gene expression of single cells from human ccRCC tissues and adjacent normal tissues using the scRNA-seq. We found that MYH9 was commonly upregulated in the ccRCC cell subgroup. Additionally, MYH9 was of highly expression in ccRCC tissues and predicted poor prognosis of ccRCC patients. MYH9 knockdown in ccRCC cells dampened their proliferative and metastatic potentials, whereas MYH9 overexpression enhanced these properties. In vivo, MYH9 also promoted ccRCC growth. Mechanistic studies showed that MYH9 played these vital roles through AKT signaling pathway. Furthermore, MYH9/AKT axis determined the responses of ccRCC cells to sunitinib treatment and might serve as a biomarker for sunitinib benefits in ccRCC patients. Thus, MYH9 might be a novel therapeutic target and prognostic predictor for ccRCC.

9 August 2022 in BMC Cancer
Verified
Journal Article
Open access
PDF file
XLXiao Liu
Xiao Liu
MJMeng Jiang
Meng Jiang
CPChenggang Pang
Chenggang Pang
JWJianning Wang
Jianning Wang
LHLijuan Hu
Lijuan Hu
Background: Sodium selenite (SSE) has been reported to exert anti-tumor effects in several cancer cells. However, the underlying mechanisms in renal cancer are yet to be elucidated. The effects of SSE on the proliferation, metastasis, and apoptosis of renal cancer cells, as well as its mechanism, were investigated in this study. Methods: ACHN and 786-O renal cancer cells were treated with different concentrations of SSE, MTT, and colony formation assays were used to detect the proliferation ability of cells. The migration of cells was detected using scratch-wound-healing and transwell-migration assays. The effect of SSE on apoptosis was assessed by AnnexinV-FITC/PI double staining. Besides, Western blotting was employed to detect the protein-expression level and elucidate the underlying pathways. We also made subcutaneous xenografts in athymic mice to verify the effect of SSE on tumor growth in vivo. Results: Our results demonstrated that treatment with SSE resulted in significant inhibition of cell proliferation and migration. Flow cytometry and Western blot confirmed that SSE induced apoptosis via the endogenous apoptotic pathway. We also confirmed that SSE treatment causes an increase in intracellular reactive oxygen species (ROS) levels, resulting in the inhibition of nuclear transcription factor-κB (NF-κB) signaling. Modulation of the ROS level by the chemical inhibitor N-acetyl-cysteine reversed the effect of SSE on cells. Similarly, subcutaneous xenografts in athymic mice models showed that SSE inhibits tumor growth in vivo. Conclusion: These results indicate that SSE inhibits proliferation and migration and induces apoptosis via ROS mediated inhibition of NF-κB signaling in renal cancer cells.

19 May 2023 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Open access
TXTing Xu
Ting Xu
DWDan Wei
Dan Wei
ZYZhe Yang
Zhe Yang
SXShanghuan Xie
Shanghuan Xie
ZYZhangbin Yan
Zhangbin Yan
JWJianning Wang
Jianning Wang
Renal cell carcinoma is one of the most common malignancies worldwide, and kidney renal clear cell carcinoma (KIRC) is the most common histopathological type of renal cell carcinoma. However, the mechanism of KIRC progression remains poorly understood. Apolipoprotein M (ApoM) is a plasma apolipoprotein and a member of the lipid transport protein superfamily. Lipid metabolism is essential for tumor progression, and its related proteins can be used as therapeutic targets for tumors. ApoM influences the development of several cancers, but its relationship with KIRC remains unclear. In this study, we aimed to investigate the biological function of ApoM in KIRC and to reveal its potential molecular mechanisms. We found that ApoM expression was significantly reduced in KIRC and was strongly correlated with patient prognosis. ApoM overexpression significantly inhibited KIRC cell proliferation in vitro, suppressed the epithelial mesenchymal transition (EMT) of KIRC cells, and decreased their metastatic capacity. Additionally, the growth of KIRC cells was inhibited by ApoM overexpression in vivo. In addition, we found that overexpression of ApoM in KIRC attenuated Hippo-YAP protein expression and YAP stability and thus inhibited KIRC growth and progression. Therefore, ApoM may be a potential target for the treatment of KIRC.

10 January 2022 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
HZHui Zhang
Hui Zhang
ZXZhipeng Xu
Zhipeng Xu
JZJie Zhang
Jie Zhang
DWDan Wei
Dan Wei
KLKai Liu
Kai Liu
JWJianning Wang
Jianning Wang